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Purpose: The presence of respiratory motion during radiation treatment leads to degradation of 
the expected dose distribution, both for target coverage and healthy-tissue sparing, particularly for 
techniques like pencil-beam scanning proton therapy which have dynamic delivery systems.  
While tools exist to estimate this degraded four-dimensional (4D) dose, they typically have one or 
more deficiencies such as not including the particular effects from a dynamic delivery, using 
analytical dose calculations, and/or using non-physical dose-accumulation methods.  This work 
presents a clinically-useful 4D-dose calculator that addresses each of these shortcomings. 
Methods: To quickly compute the 4D-dose, the three main tasks of the calculator were run on 
graphics processing units (GPUs).  These tasks were: (1) simulating the delivery of the plan using 
measured delivery parameters to distribute the plan amongst 4DCT phases characterizing the 
patient breathing, (2) using an in-house Monte Carlo simulation (MC) dose calculator to 
determine the dose delivered to each breathing phase, and (3) accumulating the doses from the 
various breathing phases onto a single phase for evaluation.  The accumulation was performed by 
individually transferring the energy and mass of dose-grid subvoxels, a technique models the 
transfer of dose in a more physically realistic manner.  The calculator was run on three test cases, 
with lung, esophagus, and liver targets, respectfully, to assess the various uncertainties in the 
beam-delivery simulation as well as to characterize the dose-accumulation technique. 
Results: 4D doses were successfully computed for the three test cases with computation times 
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ranging from 4–6 min on a server with eight NVIDIA Titan X graphics cards; the most time 
consuming component was the MC dose engine.  The subvoxel-based dose-accumulation 
technique produced stable 4D-dose distributions at subvoxel scales of 0.5–1.0 mm without 
impairing the total computation time.  The uncertainties in the beam-delivery simulation led to 
moderate variations of the dose-volume histograms for these cases; the variations were reduced 
by implementing repainting or phase-gating motion-mitigation techniques in the calculator. 
Conclusions: A MC-based and GPU-accelerated 4D-dose calculator was developed to estimate 
the effects of respiratory motion on pencil-beam scanning proton therapy treatments.  The 
calculator can currently be used to assess existing treatment plans and its quick runtime makes it 
easily usable in a future 4D-robust optimization system. 
Key words: 4D dose calculation, Monte Carlo simulation, GPU, proton therapy 
1. INTRODUCTION 
Organ motion complicates the planning, delivery, and evaluation of external-beam radiotherapy.
1,2
  
This intrafractional motion, chiefly from respiration, particularly affects the treatment of tumors located 
in the thorax and abdomen, where organ motion up to 20 mm is possible.
3
  Though non-negligible in 
photon treatment,
4
 the dosimetric consequences of target motion are enhanced in proton therapy due to 
the localized energy deposition inherent to heavy-charged-particle interactions (i.e., the Bragg peak).
5,6
  
The result is to degrade the desired treatment outcome, both in terms of target coverage and healthy-organ 
sparing. 
Intensity-modulated proton therapy
7
 delivers protons by way of pencil-beam scanning (PBS); the 
treatment plan consists of a collection of “spots,” each containing a determined number of protons at a 
given particle energy, that are delivered sequentially to specified coordinates in the patient.  The 
sequential nature of the PBS spot delivery introduces another source of motion which can interfere, both 
constructively and destructively, with the breathing motion in the so-called “interplay effect.”8–12  The 
interplay effect further distorts the delivered dose distribution, leading to a decrease in dose homogeneity 
that worsens with increased internal motion.
8
  The intricacies of the interplay effect also mean that simply 
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defining larger margins around the target volume is insufficient to regain target coverage as can be done 
in static-beam-delivery scenarios.
13
 
  Several methods have been developed either to reduce respiratory motion or to mitigate its effects.
14
  
Breath hold is a technique in which radiation is delivered while the patient holds his/her breath at a 
specific point in the respiratory cycle to precisely localize the position of the tumor.
15–17
 During 
amplitude- or phase-gated treatment, the patient’s breathing is monitored and radiation is delivered only 
during specified portions of the breathing cycle.
18–20
  Tumor tracking is the most technically difficult 
method, in which the tumor position is monitored in real-time and the beam is actively steered to match 
the tumor location.
21–25
  For PBS delivery, layer or volume repainting/rescanning involves delivering the 
planned spots multiple times, with each iteration only delivering a fraction of the total number of protons 
to a given spot. This serves to average out local hot/cold spots by spreading spot positional errors over 
different positions in the breathing cycle.  Lastly, motion effects may be mitigated through four-
dimensional (4D) optimization such that the motion is used as an input to the treatment-plan-creation 
process to develop a plan which is a priori more robust against motion.
26–29
  Currently, our institution 
manages motion using breath holding, phase gating, and repainting with the goal of additionally using 4D 
optimization in the near future. 
Faced with the complexities of 4D treatment, standard dose-calculation engines found in treatment 
planning systems (TPSs) that only consider dose to a static (3D) geometry are insufficient to fully 
describe the expected dose distribution for cases with tumor/organ motion; a 4D-dose calculator (4DDC) 
is thus necessary.  Although some TPSs offer methods to compute 4D dose, these offerings are non-ideal 
for several reasons.  First, TPSs generally employ analytical dose calculations instead of using the “gold-
standard” of Monte Carlo simulation (MC),30 which is particularly problematic for the heterogeneous lung 
geometry.
31,32
   The use of analytical calculations to greatly reduce the computation time compared to 
CPU-based MCs is no longer needed due to the development of fast MC packages which run on graphics 
processing units (GPUs).
33–36
  Secondly, in order to observe the effects of interplay in the final dose 
distribution, the dynamics of the beam’s delivery must be included as a plan may not be uniformly 
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distributed over the breathing cycle.  These dynamics are facility dependent, and consequently they are 
not typically included in TPS 4D calculations.  Lastly, studies on the mechanics of deformable dose 
accumulation indicate that, due to tissue deformation during the breathing cycle, one should individually 
accumulate energy and mass between portions of the breathing cycle as opposed to directly accumulating 
dose, as is typically performed in TPSs.
37–40
  The purpose of this work was to develop a fast general-
purpose 4DDC that accounts for beam-delivery dynamics, uses MC as the dose engine, and rigorously 
accumulates dose based on energy and mass.  This calculator could then be used to evaluate clinical 
plans, to inform the effectiveness of motion-mitigation strategies, and to calculate dose for use in 4D 
optimization. 
2. METHODS 
2.A. General overview 
Temporal information about patients was obtained through 4DCT imaging phase-sorted
41
 into 𝑁 = 10 
3D CT image sets (𝐶𝑇0, 𝐶𝑇10, … , 𝐶𝑇90 for the 0%, 10%, …, 90% phases of the breathing cycle, 
respectively) by the scanner software (Siemens Healthineers, Erlangen, Germany).  Note that the 4DDC 
was developed to be flexible in the number of phases allowed and, as such, could be used with 4DCT’s 
sorted to a larger number of phases, ultimately limited by the available GPU memory, in future studies.   
The institutional standard for motion cases was to create a single 3D image set 𝐶𝑇Avg by averaging all 
𝑁𝑔 ≤ 𝑁 phases which are to be used in the treatment.  𝑁𝑔 = 𝑁 for free-breathing deliveries while 𝑁𝑔 < 𝑁 
for gated deliveries where the portion of the breathing cycle with the 𝑁𝑔 phases is termed the “gate-on 
window.”  Structure contouring and treatment planning were then performed on 𝐶𝑇Avg.  A full structure 
set thus existed for 𝐶𝑇Avg, but usually not for the individual breathing phases.  However, a minimal 
structure set containing at least an “external” contour is required by the MC for each breathing phase (to 
limit the applicable bounds of particle transport and computation time).  The external contour from 𝐶𝑇Avg 
was rigidly transferred to the individual breathing phases using the MIM software package (MIM 
Software Inc., Cleveland, OH).  The nominal external contour consisted of the entire patient body, 
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treatment table, and immobilization device plus an additional margin. 
Dose accumulation generally requires deformation vector fields (DVFs) determined by deformable 
image registration (DIR).  The DVFs map points on the various breathing phases to their corresponding 
locations, accounting for deformation, on a designated accumulation phase.  The accumulation phase was 
a variable input to the calculator; for the studies considered in this work, the more-stable near-end-of-
exhalation phase
42
 𝐶𝑇50 was adopted.  DIR was performed using MIM, which uses the VoxAlign 
Deformation Engine™ to perform intensity-based freeform deformable registrations.43  This resulted in 
𝑁𝑔 − 1 DVFs which were imported to the 4DDC as DICOM registration files.  Note that, since the 4DDC 
was developed to accept and parse DICOM input, DIR could have been performed with any DICOM-
compliant registration system. 
The DICOM input to the 4DDC is then summarized as: 𝑁𝑔 4DCT-based CT image series, 𝑁𝑔 structure 
set files, 𝑁𝑔 − 1 registration files, and one treatment-plan file to specify the treatment fields and spot 
characteristics (location, energy, weight).  These DICOM files were processed using a PYTHON script to 
filter inputs for the 4DDC.  After the DICOM files were properly parsed, the 4DDC preformed three 
GPU-based computations, which are discussed in detail in the following subsections.  These steps were 
simulating the beam delivery (Sec. 2.B), calculating the dose via MC (Sec. 2.C), and accumulating dose 
across the breathing phases onto 𝐶𝑇50 (Sec. 2.D).  To be DICOM compliant, and clinically usable, the 
final product of the 4DDC should be a DICOM dose file which can be imported and viewed in any TPS.  
As such, the last step of the 4DDC was another PYTHON script which converted the final accumulated-
dose distribution on 𝐶𝑇50 to a DICOM dose file. 
2.B. Beam-delivery simulation 
The beam-delivery simulation determined what portions of the treatment plan would be delivered 
during each breathing phase.  This was accomplished by simultaneously tracking the timing of the patient 
breathing, to indicate the current breathing phase, and the timing of the plan delivery. The end result of 
these simulations was a set of 𝑁𝑔 subplans, per field, indicating the number and weighting of spots which 
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would be delivered on each breathing phase.  The beam-delivery simulation was performed in a parallel 
manner on a GPU, using a CUDA C kernel, with all fields simultaneously simulated. 
The 4DDC was designed to be a flexible tool by giving the user control over many aspects of the 
delivery simulation mimicking variables and options found in the clinic.  The user could specify whether 
to perform a phase-gated delivery and define the associated beam-on window.  The plan could also be 
reorganized to create an isolayered-repainted
44
 delivery with a specified maximum monitor unit (MU) per 
spot delivery.  A source of uncertainty in the delivery was the breathing phase during which delivery 
commences, which the user could either specify or allow to be randomly selected. 
The length of each breathing phase 𝑡𝑝ℎ was characterized in the simulation by a user-input breathing 
period mean 𝜇 and standard deviation 𝜎.  If the breathing were perfectly uniform, 𝑡𝑝ℎ would be 𝑡𝑝ℎ =
𝜇/𝑁.  As patient breathing patterns are not perfectly uniform, 𝑡𝑝ℎ was instead a random variable 
described as 𝑡𝑝ℎ ∼ 𝒩(𝜇, 𝜎)/𝑁, i.e., it was found by sampling a normal distribution 𝒩(𝜇, 𝜎), 
characterized by 𝜇 and 𝜎, and then dividing by the total number of phases.b  This sampling allowed for 
some measure of irregular breathing, without requiring an imported breathing trace or 4D-MRI.  
Clinically, the appropriate values for 𝜇 and 𝜎 for a given patient could be obtained by measuring a 
breathing trace or from the 4DCT reconstruction software.  For the studies presented in this manuscript, 
these values were treated as input variables whose values affect the overall uncertainty in the 4DDC 
result. 
Our institution employs a Hitachi ProbeatV5 synchrotron-based system with 97 discrete energy levels 
ranging from 71.3 to 228.8 MeV.  The timing for spot delivery from such a system was well characterized 
in Ref. 45 and is summarized in App. A.  On the assumption that the characterized system behaves 
similarly to ours, the values given in Ref. 45 were used for the 4DDC timing simulation with one 
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exception.  When beam extraction begins, the initial 70 ms of the beam are discarded as it is of poor 
quality; when the delivery is non-gated, this occurs immediately after resetting the synchrotron.  In a 
gated delivery, however, after the synchrotron resets it can be held in the accelerator until receiving a 
gate-on signal, at which point the 70 ms of beam is discarded.  Only non-gated deliveries were considered 
in Ref. 45 and, as such, this time was combined into the synchrotron-reset time.  For the 4DDC, the 
beam-discarding time was separately tracked to allow for gated deliveries.  The 4DDC also optionally 
allowed for uncertainty in these delivery parameters; the uncertainties were either provided in Ref. 45 or 
obtained from the authors themselves.  Uncertainty values were sampled from a Gaussian distribution 
with mean and standard deviation corresponding to the central value and uncertainty for the given 
parameter. 
The outcome of the beam-delivery simulation, and thus the final 4D-dose distribution and dose-
volume histograms (DVHs), could be affected by the three sources of uncertainty identified above.  The 
effect of these uncertainties was considered by running 25 trials of the 4DDC where, for each trial, the 
initial-breathing phase, breathing period, and synchrotron delivery parameters were simultaneously varied 
according to their statistical distributions.  These distributions were: starting phase ~𝒰(𝐶𝑇0, 𝐶𝑇90), 
synchrotron parameters ~𝒩(𝜇, 𝜎) (as described above), and breathing period ~𝒰(3,7) s.  Here, 
~𝒰(𝑎, 𝑏) indicates random selection from a discrete uniform distribution inclusively spanning from 𝑎 to 
𝑏.  These 25 trials were also used to characterize the timing of the GPU-based components of the 4DDC.  
The effect of motion mitigation was considered by repeating the 25 trials using a gated delivery with 
protons delivered on 𝐶𝑇30–𝐶𝑇70 (50% duty cycle) and then again for free breathing with a max MU of 
0.005 MU for isolayered repainting. 
2.C. Dose calculation MC 
The GPU-based MC dose-calculation engine used by the 4DDC has been previously described in 
Refs. 33 and 34.  The simulation is a class II condensed-history proton transport package which is capable 
of simulating 1 × 107 protons in less than 30 s on a gaming graphics card.  As discussed in Sec. 2.D, the 
dose-accumulation algorithm requires knowledge of the tissue density of each CT voxel.  This 
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information is already calculated internally by the MC, converting Hounsfield Units to material density,
46
 
and minimal changes to the MC package were required to extract this information as an additional output.  
The outputs from a single MC run were the dose for and the density of each original CT voxel which 
received non-zero dose during the simulation.  In these simulations, the dose grid (3D bins into which 
dose is counted) was identical to the CT-voxel grid, which is not the case in most TPS calculations where 
the dose grid may have coarser resolution.  For the 4DDC, 𝑁𝑔 simulations were performed per field.  The 
4DDC distributed the MC jobs over all available GPU devices on the system; the results presented here 
were run on a research system with eight NVIDIA (NVIDIA Corporation, Santa Clara, CA) GeForce 
GTX Titan X devices. 
2.D. Dose accumulation 
2.D.1. DVF calculation 
The end result of any DICOM-compliant DIR software is a deformable spatial registration DICOM 
file which encodes a DVF as detailed in App. B.  The DVF transformation can be mathematically 
expressed as
  
 𝒓𝑓 = 𝑇
0→𝑓(𝒓0), (1) 
where 𝒓0 is a location on the initial image 𝐼0, 𝒓𝑓 is the mapped location on the final image 𝐼𝑓, and 
𝑇0→𝑓(𝒓0) is a function which computes the DVF translation at 𝒓0.  In the DICOM file, the DVF is 
encoded as a three-dimensional grid on 𝐼0 along with the translations at the centers of this grid’s voxels.  
Note that, to reduce file size, only minimal information about this grid is actually stored in the file (see 
App. B).  For the 4D-breathing problem, a DVF was needed for each non-accumulation phase in the 
gating window.  Note that whether an accumulation phase corresponds to 𝐼0 or 𝐼𝑓 in Eq. (1) depends on 
the deformable-dose summation technique used (see Sec. 2.D.2); instead, the terminology of Ref. 40 is 
adopted here such that the accumulation phase is called the reference image 𝐼𝑅 and all other phases from 
which dose is accumulated are called source images 𝐼𝑆’s.   
To use the DVF information for dose accumulation, the 4DDC needed first to calculate the full DVF 
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based on the stored minimal-grid information and then to interpolate between deformation-grid voxel 
locations to derive the deformation at dose-grid (CT voxels) locations.  These steps were performed in 
two separate CUDA C calls on the GPU, the first of which served to construct the DVFs for all 𝐼𝑆’s; 
running on a one-thread-per-deformation-grid-voxel basis to calculate 𝒓𝒇 for all voxels.  When this kernel 
finished, the computed values for 𝒓𝒇 were reformatted and bound to 3D texture memory on the GPU. 
Texture memory is a special type of device memory allowed in CUDA C which increases performance 
for applications with spatial locality (nearby threads accessing addresses which are themselves near each 
other) and which provides linear interpolation (trilinear for 3D textures).  Because nearby CT voxels will 
typically have similar deformations, both of these properties made textures desirable for use here.  The 
second CUDA C kernel accumulated the MC-calculated doses from each breathing phase onto 𝐶𝑇50.  
However, a discussion of dose accumulation techniques is first required before detailing this GPU kernel. 
2.D.2. Deformable dose accumulation 
There is a large body of literature surrounding various techniques for performing deformable dose 
summation.
37–40,47–54
  In all methodologies, the final dose 𝐷𝑖 for voxel 𝑖 on 𝐼𝑅 is 
 𝐷𝑖 = 𝐷𝑖
𝑅 + ∑𝐷𝑖
𝑆
𝑆
, (2) 
where 𝐷𝑖
𝑆 is the dose from source phase 𝑆 which maps to voxel 𝑖 and 𝐷𝑖
𝑅 is the dose originally delivered 
to 𝐼𝑅.  The difference between methodologies lies in the determination of 𝐷𝑖
𝑆.  Note that, for the 4DDC, 
any relative weighting between the phases was accounted for by the beam-delivery simulation, and thus 
there were no additional weight factors between the phases in Eq. (2).   The various methods can be 
sorted into three general categories:
47
 dose-interpolation methods (DIMs), energy-/mass-transfer methods 
(EMTMs), and voxel-warping methods (VWMs).
48,49,55
  Both a DIM and an EMTM were implemented in 
the 4DDC. 
The general approach for DIMs considers each voxel on 𝐼𝑅 by:
47,51,52,54,56
 determining where the 
voxel’s location maps to on each 𝐼𝑆, finding the appropriate doses at these locations, pulling these doses 
back to 𝐼𝑅, and assigning them to the given voxel.  This approach guarantees that every voxel on 𝐼𝑅 
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receives a mapped dose, but, as there is generally no one-to-one correspondence between voxels on 𝐼𝑅 
and any given 𝐼𝑆,
38,40
 it does not guarantee that all dose-filled voxels on the 𝐼𝑆’s are pulled back or that the 
rearrangement of mass is properly handled.  The method implemented in the 4DDC is the trilinear-
interpolation method of Ref. 54 and is illustrated in Fig. 1.  For each source phase 𝑆: each voxel on 𝐼𝑅 was 
split into 𝑛 × 𝑛 × 𝑛 subvoxels, the central location of each subvoxel 𝒓𝑖𝑘 was mapped to 𝐼𝑆 giving 
𝑇𝑅→𝑆(𝒓𝑖𝑘), the trilinearly-interpolated dose at this location  ?̃?
𝑆[𝑇𝑅→𝑆(𝒓𝑖𝑘)] was computed and the final 
𝐷𝑖
𝑆 was then 
 𝐷𝑖
𝑆 =
1
𝑛3
∑ ?̃?𝑆
𝑛3
𝑘=1
[𝑇𝑅→𝑆(𝒓𝑖𝑘)]. (3) 
 
 
Fig. 1 Two-dimensional representation of the dose-
accumulation methods implemented in the 4DDC showing the 
DIM (top) and EMTM (bottom) techniques.  In each case, dose 
is accumulated onto the selected voxel 𝑖 (highlighted in solid 
orange) on 𝐼𝑅 (left) from a single source phase 𝐼𝑆 (right) where 
the voxel warps to encompass a larger area.  The DIM 
technique divides 𝑖 into subvoxels (dashed lines) and maps 
(dotted lines) their centers 𝑟𝑖𝑘 (small dots) to 𝐼𝑆.  The dose at 
the mapped location is calculated by interpolating nearby dose-
grid locations on 𝐼𝑆 and pulled back (solid lines, only two 
shown for clarity) to 𝐼𝑅.  The total dose in 𝑖 is then the average 
of all interpolated subvoxel doses.  The EMTM technique 
instead subdivides the 𝑗 voxels on 𝐼𝑆 and considers all 
subvoxels whose centers 𝑟𝑗𝑘   map to 𝑖.  The energy and mass 
from all such subvoxels are individually summed with the final 
dose in 𝑖 being the ratio of the summed energy to the summed 
mass. 
Even with the subvoxelization and interpolation above, fundamental issues with pulling dose based on 
𝐼𝑅’s voxels remain (as demonstrated in Refs. 38 and 40) due to voxels merging and/or splitting between 
the images.  Instead, EMTMs aim to explicitly use the definition of dose by decoupling the tracking of 
energy and mass during the deformation and pushing them from the 𝐼𝑆’s to 𝐼𝑅.
37–40
  A defining 
characteristic of EMTMs is that, to push the energy/mass, the DVFs used go in the opposite direction as 
those used in DIMs.  The method implemented in the 4DDC was similar to that of Ref. 37 and is also 
illustrated in Fig. 1. As in the DIM implementation, the initial voxels were split into 𝑛3 subvoxels but, in 
this case, the initial voxels were from each 𝐼𝑆.  The mass of and the energy deposited in the 𝑘
th subvoxel 
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of voxel 𝑗 (𝑀𝑗𝑘 and 𝐸𝑗𝑘 , respectively) were first calculated as 
 𝑀𝑗𝑘 = 𝜌𝑗𝑣𝑘 ,        𝐸𝑗𝑘 = 𝑀𝑗𝑘𝐷𝑗, (4) 
where 𝐷𝑗 is the dose in voxel 𝑗, 𝜌𝑗 is its density as calculated by the MC (see Sec. 2.C), and 𝑣𝑘 is the 
volume of the subvoxel (same for all subvoxels), and.  The dose to voxel 𝑖 from phase 𝑆 was then 
computed as 
 
𝐷𝑖
𝑆 =
∑ 𝐸𝑗𝑘𝑗𝑘∈𝕁
∑ 𝑀𝑗𝑘𝑗𝑘∈𝕁
,  (5) 
with the mathematical set 𝕁 defined as  
 𝕁 ≡ {𝑗𝑘|𝑇
𝑆→𝑅(𝒓𝑗𝑘) ∈ 𝑉𝑖},  (6) 
that is, the set of all subvoxels whose center 𝒓𝑗𝑘  maps into the volume 𝑉𝑖 contained by voxel 𝑖.  The 
authors of Ref. 37 categorized this method with DIMs as a “dose mapping” instead of an “energy 
transfer” model as it uses a discretized dose at the fundamental level (they describe it as a mass-weighted 
dose). However, given the form of Eq. (5) and the directionality of the required DVFs, it is here 
categorized with the EMTMs instead of the DIMs.  Note also that those authors compared this method to 
other accumulation techniques, including the DIM of Eq. (3), and found this style of EMTM to be 
superior; the EMTM technique was thus the default technique in the 4DDC. 
Both the DIM from Eq. (3) and the EMTM from Eqs. (4)–(6) were implemented in the 4DDC to run 
on the GPU.  Input options allowed the user to choose both the accumulation method and the voxel-
subdivision scale 𝑛 which was used by either method.  The GPU implementation was such that all of the 
dose files generated by the MC were read in and transferred to the GPU as 3D texture memories; the 
built-in trilinear interpolation of textures was used for the DIM technique.  The computation then 
proceeded with a single main-voxel-per-thread approach; for the DIM, each voxel on 𝐶𝑇50 was assigned a 
thread per non-accumulation phase while, for the EMTM, each voxel on a non-accumulation phase was 
assigned a thread.  Assigning a thread per each subvoxel for all phases would require more memory than 
available on the GPU, thus looping over subvoxels was performed on the device which could slow the 
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kernel for large 𝑛.  To avoid race conditions in the EMTM parallelization, CUDA C atomic functions 
were used when summing energy and mass.  After the initial kernel for either method was run, a second 
kernel was called, with one thread per voxel on 𝐼𝑅, to perform the final dose summation of Eq. (2).  The 
final accumulated dose was then written to a binary file such that it could be converted to a DICOM dose 
file as described in Sec. 2.A.  Since the DVFs typically cover less than the full CT geometry, a mask was 
applied to only report dose in the volume encompassed by all DVFs to avoid artifacts in the 4D dose. 
  The determination of an appropriate value for the voxel-subdivision scale 𝑛 is presented in the results 
and discussion sections.  This determination considered the facts that at larger values of 𝑛 the 4D-dose 
distribution should be more stable but there is also the potential at large 𝑛 for the dose-accumulation 
component to become overly time consuming (because each GPU thread loops over all subvoxels for a 
given primary voxel).  As such, both the convergence of DVHs and the time to complete the dose 
accumulation were studied as functions of 𝑛 to determine an optimal scale of voxel subdivision. 
2.E. 3D comparison tests 
Two preliminary tests were performed to benchmark the 4DDC against known 3D situations.  The first 
involved creating a mock 4D data set by using the same 3D CT image set for all breathing phases coupled 
with a manually-entered “identity” DVF which mapped each point to itself.  Since each breathing phase 
now had an identical geometry, and there was no warping applied between phases, the result should 
match the 3D-static dose as found by running the original MC calculator on 𝐶𝑇50.  The second test was to 
give 𝐶𝑇50 as the only phase to the 4DDC.  In this case, the beam-delivery simulation should place the 
entire plan on 𝐶𝑇50 as if it were a non-motion site and thus require no dose warping.  The results of both 
tests gave the expected match with the 3D-static dose. 
2.F. Patient test-case studies 
Three retrospective test cases were used to study the results and characterize the various uses of the 
4DDC.  The patients were selected to cover a variety of tumor locations with the patients having lung, 
esophagus, and liver targets, respectively.  Treatment plans were originally created (on 𝐶𝑇Avg) using a 
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commercially available TPS (Eclipse, Varian Medical Systems, Palo Alto, CA) at the time of treatment.  
The patients were treated with no active motion mitigation (free breathing), however the plans were 
delivered with isolayered repainting
44
 with a maximum MU per spot delivery of 0.005 MU.  To assess the 
characteristics of the 4DDC, and the effects of repainted and gated deliveries, alternative plans were 
considered where the original plans were recast to the non-repainting maximum per spot delivery of 
0.1 MU.  Characteristics of the plans and geometries for the cases are given in Table I. 
Characteristic Lung Esophagus Liver 
Prescription [Gy] 60 50 67.5 
Fields 3 2 3 
Tumor motion [mm] 5.4 5.3 7.5 
Tumor volume [cm
3
] 79.6 204.4 581.0 
CT voxel size [mm] 1.27 × 1.27 × 2.00 1.27 × 1.27 × 2.00 1.27 × 1.27 × 1.50 
CT voxel grid size 427 × 246 × 161 430 × 272 × 235 452 × 307 × 281 
DVF voxel size [mm] 2.55 × 2.54 × 2.56 2.55 × 2.55 × 2.57 2.55 × 2.54 × 2.57 
DVF voxel grid size 175 × 109 × 126 184 × 122 × 218 184 × 135 × 164 
Table I Characteristics of the plans and geometries for the test patients considered with the 4DDC.  Sets of three numbers give 
the appropriate values in the 𝑥 × 𝑦 × 𝑧 dimensions, respectively.  Tumor motion was estimated as the maximum displacement, 
between any two phases, of the centroid of the target’s volume while the tumor volume was estimated as the target’s mean 
volume across all phases.  CT voxel sizes were the standard resolutions used for these treatment sites while the DVF voxel size 
and grid were automatically determined by MIM, the DIR software used. 
For a full analysis, region-of-interest (ROI) contours were required on 𝐶𝑇50 for assessment of the 
accumulated-dose distribution under various scenarios.  For each case, one healthy-tissue ROI and the 
clinical target volume(s) (CTVs) were identified on 𝐶𝑇50.  The esophagus and liver cases had high- and 
low-dose CTVs while the lung case had a single CTV.  The healthy-tissue ROIs for the cases were the 
esophagus, heart, and non-target liver tissue for the lung, esophagus, and liver cases, respectively.  For all 
scenarios studied with the 4DDC, the DVH for each ROI was evaluated. 
3. RESULTS 
3.A. Baseline results 
The 4D-accumulated dose distribution on 𝐶𝑇50 for the lung case is shown in Fig. 2.  The parameters 
used for the dose shown in the figure will be called the “4D-baseline” values which correspond to using 
all ten phases (a non-gated delivery), a starting phase of 𝐶𝑇0 (arbitrarily selected), a breathing period of 
5 ± 0.5 s (arbitrarily selected), the nominal experimental values for the synchrotron delivery parameters 
(from Ref. 45), and EMTM dose accumulation with a voxel-subdivision scale of 𝑛 = 5 (see Sec. 4.A). 
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Fig. 2 also gives the portions of the 4D-accumulated dose that were delivered to 𝐶𝑇50 and 𝐶𝑇0 (which has 
been deformed to 𝐶𝑇50 in the figure), highlighting the variation between phases.  Additionally, the 4D-
baseline dose is compared to the 3D-static dose (as calculated with the second test described in Sec. 2.E).  
The 3D to 4D comparison serves to give a sense of the effects of motion on the distribution.   
 
Fig. 2 Isodose lines (percentage of prescription) on 𝐶𝑇50 for 
the lung case showing the dose distribution from the 4D-
baseline (all phases deformed to and summed on 𝐶𝑇50) and 
3D-static deliveries.  Also shown are the components of the 
4D-baseline dose which were delivered on 𝐶𝑇0 and 𝐶𝑇50 
individually, with the dose delivered to 𝐶𝑇0 presented after 
warping it to 𝐶𝑇50.  The differences on the far-right sides of 
the distributions are due to the DVF-defined mask applied in 
the 4DDC which is not applied for the 3D-static or 𝐶𝑇50 only 
cases, which use no DVF. 
3.B. Dose-accumulation characterization 
The 4DDC was characterized as a function of voxel-subdivision scale 𝑛 (recall that each primary 
voxel was split into 𝑛3 subvoxels during dose-accumulation) while otherwise using the 4D-baseline 
values for the delivery parameters.  Fig. 3 shows DVHs for both the EMTM and DIM accumulation 
techniques for 𝑛 = 1, 2, and 100 as a test for convergence in the 4D-dose distribution.  For the DIM case, 
the curves are consistent regardless of the degree of subvoxelization.  For the EMTM case, the DVHs 
with no subdivision (𝑛 = 1) differ substantially from those with subdivision.  However, the equivalence 
of the 𝑛 = 2 and 100 curves indicates convergence already with eight subvoxels.  This degree of 
subdivision corresponds to subvoxel dimensions of 0.5–1.0 mm as indicated by Table I. 
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Fig. 3 DVHs for all ROIs for the lung (left), esophagus (middle), and liver (right) cases using EMTM (top) and DIM (bottom) for 
dose accumulation under various voxel-subdivision scales 𝑛.  Captions in the middle apply to both top and bottom plots.  For the 
DIM, the DVHs computed with no voxel subdivision (𝑛 = 1) are already consistent with those of 𝑛 = 100.  For the EMTM, the 
DVHs for 𝑛 = 1 substantially differ, however, convergence with 𝑛 = 100 is already seen by 𝑛 = 2.  Abbreviations – CTV𝑋: CTV 
at a prescription of 𝑋 Gy, Livernt: non-target liver. 
The time to complete the accumulation step for each patient and accumulation technique is given in 
Fig. 4.  For 𝑛 ≲ 5, the time is relatively flat and is dominated by file input/output.  The EMTM technique 
requires slightly more time here as it must load the voxel densities in addition to the doses.  For 𝑛 ≳ 5, 
the time varies as 𝑛3 which is indicative of looping over subvoxels.  The EMTM technique is quicker in 
this regime due to internally controlled differences in how the GPU caches texture memory when 
sampling the DVF. 
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Fig. 4 Time to complete the dose-accumulation stage of the 4DDC as a function of voxel-subdivision scale 𝑛.  The flat behavior 
at low 𝑛 is the file input/output time; the EMTM additionally reads the density file.  The 𝑛3 behavior at high 𝑛 is due to looping 
over subvoxels on the GPU threads. 
3.C. Delivery simulation characterization 
The effects on the DVH curves from sampling the beam-delivery uncertainties 25 times are seen in 
Fig. 5.  Mild variations in the target DVHs are seen with the breathing period having the largest effect, 
followed by the starting phase selection.  The times to complete the GPU-based components of the 4DDC 
based on these 25 trials are given in Table II.  The largest contributor to the time was the particle MC at 
2.5–3.0 min, followed by the dose-accumulation step at 1–2 min while the beam-delivery simulation took 
only ~7 s.  The effects of repeating the sampling of beam-delivery uncertainties while instead using a 
gated or repainted delivery are shown in Fig. 6. The 0.005 MU repainted value is the value used clinically 
(see Sec. 2.F) and thus the repainted trials represent the original treatment plan. 
 
Fig. 5 DVHs for all ROIs for the lung (left), esophagus (middle), and liver (right) cases for 25 different uncertainty trials.  For 
each trial, the starting phase, breathing period, and synchrotron delivery parameters were sampled according to their uncertainties 
(see main text).   The text labels indicate the grouping of curves corresponding to the given ROI; the width of a particular 
grouping is indicative of the uncertainty for that ROI. Abbreviations – CTV𝑋: CTV at a prescription of 𝑋 Gy, Livernt: non-target 
liver. 
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Component 
 
Lung 
[s] 
Esophagus 
[s] 
Liver 
[s] 
Beam-Delivery Sim. 6.7 ± 0.1 7.0 ± 0.1 7.4 ± 0.1 
Particle MC 156.8 ± 2.1 135.0 ± 4.4 174.9 ± 2.1 
Dose Accumulation 45.2 ± 0.7 90.2 ± 0.5 121.9 ± 1.7 
Total 245.8 ± 2.2 297.4 ± 12.2 367.3 ± 9.3 
Table II Time, in seconds, to complete the main components of the 4DDC as well as the total time for each of the three cases.  
The beam-delivery simulation and dose accumulation were performed on a single GPU while the particle MC was performed 
across eight GPUs.  Time not accounted for in the given components is due to DICOM-file input/output and transferring data 
between GPU components. 
 
Fig. 6 DVHs for all ROIs for the lung (left), esophagus (middle), and liver (right) cases for 25 different uncertainty trials each for  
isolayered-repainted (top) and gated (bottom) deliveries.  The text labels indicate the grouping of curves corresponding to the 
given ROI; the width of a particular grouping is indicative of the uncertainty for that ROI.  The uncertainties are reduced relative 
to Fig. 5. Abbreviations – CTV𝑋: CTV at a prescription of 𝑋 Gy, Livernt: non-target liver. 
4. DISCUSSION 
4.A. Characterization and performance 
Selecting an optimal value for the voxel-subdivision scale was done by comparing Fig. 3 and Fig. 4; 
although dose convergence was seen at 𝑛 = 2, there was no time penalty until 𝑛 ≃ 5.  Because further 
subdivision should, in principle, provide more accurate results, 𝑛 = 5 was selected as the optimal value 
and used for the 4D baseline as described in Sec. 3.A.  The uncertainties in the beam-delivery simulation 
created mild variations in the target DVHs and, as expected, using a motion mitigation technique reduced 
the incidence of lower-coverage curves and tightened the overall distributions. 
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Using the optimal value of 𝑛, the most time consuming component of the 4DDC was the particle MC 
as seen in Table II.  However, as discussed in Sec. 2.C, the MC was distributed amongst eight GPUs and 
thus this time could be reduced by spreading the MC jobs amongst more GPUs.  The differences in timing 
between patients are related to the voxel-grid sizes and number of fields as given in Table I; larger 
treatment areas with sparser dose distributions lead to more voxels with non-zero dose and less efficient 
texture caching, while more fields lead to more MC runs and subsequently more dose files to be loaded 
by the accumulation component. 
4.B. Uncertainties and limitations 
The 4DDC can only be as accurate as the assumptions that its underlying components are based on.  
For the beam-delivery simulation, this includes the characterization of the synchrotron parameters.  The 
values from Ref. 45 used in the simulation were not measured with our institution’s synchrotron and, 
although that system is the same Hitachi design and configuration, no two systems are entirely identical 
and it is an assumption that these parameters are applicable to the our synchrotron.  Additionally, 
variation in the beam current is seen in the day-to-day operations of the synchrotron and although some 
uncertainty on the current was studied above, it cannot fully encapsulate the observed stochastic variation.  
Lastly, the delivery simulation was developed assuming that a full synchrotron reset is performed 
between all energy layers, so-called “single-energy extraction.”  However, an alternative mode where 
protons can be decelerated within the synchrotron such that a full reset is not required when stepping 
down in energy, so-called “multi-energy extraction,” is currently being used.  Delivering such a plan 
would require moderate modifications to the existing beam-delivery simulation. 
There are also inherent limitations with regard to 4DCTs, DIRs, and EMTM-style dose accumulation.  
This study phase-sorted the 4DCTs into 10 phases, however the type of sorting
41
 and number of phases 
used
57
 have both been shown to affect the resulting 4D-dose distribution; some studies indicate that using 
more phases and/or interpolating between phases provides more accurate 4D-dose assessment.
58
  Many 
different DIR algorithms exist with variations between metrics and transformation approaches,
59
 and these 
differences can have dosimetric effects: the CTV volume receiving 95% of the maximum dose can vary 
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by 5–10% between DIR algorithms.60  For dose accumulation, DIMs and EMTMs use DVFs with 
opposite directionality and thus a true comparison between these methods should use a DIR method 
which is analytically invertible. The free-form style transformation of MIM used for this study is not 
invertible, but, as a systematic comparison is beyond the scope of this work (see, e.g., Ref. 37) this small 
effect was not considered.  The EMTM-style dose accumulation presented above explicitly uses the 
density of each voxel, and any uncertainty in its calculation from Hounsfield units would necessarily 
impact the dose-accumulation results. 
4.C. Current and future uses 
  Given the results in Sec. 3.C and the discussion above, it needs to be emphasized that a single run of 
the 4DDC should not be interpreted as giving the exact 4D dose.  Instead, it should be viewed as giving 
an estimate of the scale of the effect of motion and multiple runs of the 4DDC should be used to gauge 
the uncertainty in that estimate.  Notwithstanding the above, the results of the 4DDC are still clinically 
relevant as they give a more accurate assessment of the effects from motion, particularly those from 
interplay effects, than simple solutions commonly used such as calculating the dose statically on only 𝐶𝑇0 
and/or 𝐶𝑇50.  Experimental validation of any 4DDC will increase confidence in its use (see, e.g., Ref. 61) 
and studies for such validation of the presented 4DDC are underway. 
As indicated in Sec. 1, 4D optimization is a more advanced technique for mitigating the effects of 
motion.  In particular, an in-house MC-based and GPU-accelerated robust physical- and biological-dose 
optimizer has been developed to quickly generate treatment plans.
62,63
  Given the shared MC and GPU 
framework between this optimizer and the presented 4DDC, integrating the two together into a 4D-robust 
optimizer is a future direction for study. 
5. CONCLUSIONS 
This work presented a fast, clinically relevant, 4D-dose calculator which is based on MC-simulated 
dose.  This is accomplished by three GPU-accelerated tasks which respectively simulate the delivery of a 
plan amongst 4DCT breathing phases to generate subplans on each phase, calculate the dose of each 
subplan via MC simulation, and accumulate the subdoses onto the near-end-exhale phase via DVFs.  This 
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calculator was characterized and tested with three retrospective test cases, where stable 4D-dose 
distributions were computed in 4–6 min.  The next steps include experimental validation and development 
of a 4D-robust optimizer to generate treatment plans which are less sensitive to motion. 
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A. DESCRIPTION OF SYCHROTRON DELIVERY OF PROTONS 
As mentioned in Sec. 1, in PBS the beam is delivered as individual spots which each have a specific 
(𝑥, 𝑦) position and energy; all spots of the same energy form a “layer.” A general schematic of the 
relevant timing parameters to deliver a layer from a synchrotron is shown in Fig. 7 and proceeds as 
follows: low energy protons are injected into the synchrotron and then accelerated to the desired energy.  
Once at energy, there is a short preparation period, to check the beam energy and prepare the steering 
magnets, before either holding the beam in the accelerator to wait for a gate-on signal or immediately 
proceeding to beam extraction.  When extraction does begin, a second preparation period occurs to 
discard the initial 70 ms of low-quality beam.  Extraction ceases when one of a number of conditions is 
met: all spots of the given layer are completed, the charge capacity of the synchrotron (∼2 nC) is 
depleted, or the flat-top and/or extraction time limits (∼8 s) are exceeded.  The last two conditions are 
imposed as the phase-space quality of the remaining protons in the synchrotron can only be maintained 
for so long.  Once extraction ends, preparation is made for deceleration followed by deceleration itself 
and then the beginning of a new cycle.  The time to reset the synchrotron between layers, including the 
preparation phases which precede and follow the reset, is energy dependent and grouped together in the 
“layer-switch time” (∼2 s). 
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Fig. 7. Schematic of the synchrotron delivery pattern demonstrating the various components of the delivery timing for (top) the 
beam energy profile and (bottom) the delivery of individual spots.  Low-energy protons are injected into the synchrotron, 
accelerated to the desired energy, held there until the energy layer is complete or a parameter limit is exceed, and then 
decelerated.  While at energy, time is spent undergoing three short preparation periods, waiting for a gate signal, and extracting 
protons.  During extraction, spots are delivered as individual spills which require a finite time to deliver (width of vertical bars) 
and switch between.  Various quantities relevant to the 4DDC computation are also indicated, including the flat-top, extraction, 
gate-holding, and layer-reset times. 
While at a given energy, there is a certain beam current (MU/s) which dictates the rate at which 
protons are spilled from the synchrotron and, therefore, there is a finite time, called the “spot-spill time,” 
required to deliver a spot of any given MU at any given energy.  It also takes finite time, called the “spot-
switch time” to redirect the beam between spots (during which the beam is off) which is dictated by the 
speed of steering magnets and the time to prepare and verify the magnet operation before and after 
repositioning the beam.  See Ref. 45 for further details and specific values for each timing component. 
B. DEFORMATION VECTOR FIELD CALCULATION 
The DICOM standard for encoding DVFs, as would be computed by any compliant DIR software, is 
given by
64 
 [
𝑥𝑓
𝑦𝑓
𝑧𝑓
1
] = 𝑀Post (𝑀Pre [
𝑥0
𝑦0
𝑧0
1
] + [
Δx
Δy
Δz
0
]), (7) 
where (𝑥0, 𝑦0, 𝑧0) is the location of the center of a DVF-grid voxel on the initial image 𝐼0, (Δx, Δy, Δz) is 
the translation of this voxel’s center, 𝑀Pre/Post  are rigid transformations that could be applied pre- and 
post-deformation (for DIR between 4DCT phases, these are both the 4 × 4 identity matrix), (𝑥𝑓 , 𝑦𝑓 , 𝑧𝑓) is 
22 
 
the mapped location on the final image 𝐼𝑓, and all locations are specified in millimeters relative to the 
scanner’s frame of reference.  In order to compress the file size, the individual voxel locations on 𝐼0 are 
not stored in a DICOM file, but instead must be computed from the stored minimal information as 
 [
𝑥0
𝑦0
𝑧0
1
] =
[
 
 
 
𝑋Row𝛿𝑋 𝑋Col.𝛿𝑌 𝑋Dep.𝛿𝑍 𝑥Start
𝑌Row𝛿𝑋 𝑌Col.𝛿𝑌 𝑌Dep.𝛿𝑍 𝑦Start
𝑍Row𝛿𝑋 𝑍Col.𝛿𝑌 𝑍Dep.𝛿𝑍 𝑧Start
0 0 0 1 ]
 
 
 
[
𝑖
𝑗
𝑘
1
], (8) 
where (𝑥Start, 𝑦Start, 𝑧Start) is the location of the starting (upper-left corner) voxel of the deformation grid, 
(𝛿𝑋 , 𝛿𝑌 , 𝛿𝑍) are deformation-grid resolutions, 𝑼 = (𝑋Row, 𝑌Row, 𝑍Row) are the row direction cosines, 
𝑽 = (𝑋Col., 𝑌Col., 𝑍Col.) are the column direction cosines, 𝑾 = (𝑋Dep., 𝑌Dep., 𝑍Dep.) are the depth direction 
cosines such that 𝑾 = 𝑼 × 𝑽, and (𝑖, 𝑗, 𝑘) are the deformation-grid voxel indices for the given voxel.  
The DICOM standard also then supplies the total number of voxels in each direction (𝑁𝑋 , 𝑁𝑌 , 𝑁𝑍) such 
that 0 ≤ 𝑖 < 𝑁𝑋 and similarly for the other dimensions.  The DICOM standard additionally states that the 
translation for points between DVF-grid voxel centers is to be found by interpolating the surrounding grid 
points, i.e., 𝑇0→𝑓(𝒓) from Eq. (1) is the trilinearly interpolated position on 𝐼𝑓 for the point 𝒓 on 𝐼0.  Using 
a DVF then entails two aspects (1) calculating the location and translation at each DVF-grid location and 
(2) interpolating these positions to the voxel grid of interest (e.g., CT or dose grids). 
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